![Vanessa Procter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vanessa Procter
Företagsledare/Principal på
Indivior Ltd.
Profil
Vanessa Procter is Executive Vice President-Corporate Affairs at Indivior Pharmaceuticals, Inc. and Indivior Ltd. starting in 2025.
Former roles include Head-Government Affairs at Alexion Pharmaceuticals, Inc., Senior Vice President-External Affairs at SAGE Therapeutics, Inc., and Member of the United States Congress.
Education includes an undergraduate degree from Gettysburg College.
Aktiva positioner av Vanessa Procter
| Företag | Position | Start |
|---|---|---|
Indivior Ltd.
 Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Företagsledare/Principal | 2025-07-07 |
Tidigare kända positioner av Vanessa Procter
| Företag | Position | Slut |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Generell Rådgivare | - |
United States Congress | Företagsledare/Principal | - |
| SAGE THERAPEUTICS, INC. | Företagsledare/Principal | - |
Vanessa Procters utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
3
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Indivior Ltd.
Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Health Technology |
Gettysburg College
 Gettysburg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
United States Congress |
